glp 1 drugs fda approved for weight loss Eli Lilly GLP-1 pill Foundayo obesity How GLP-1 medications are transforming

Clinicians should interpret preliminary findings with appropriate caution and await results from adequately powered randomized controlled trials before drawing firm conclusions about neuroprotective benefits

The researchers concluded that berberine might be a good choice for patients with NAFLD and glucose metabolic disorders

Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA

A letter reported the clinical manifestations of the GLP-1RA exenatide in acute stroke patients for the first time, including treatment regimens and adverse reactions (107)